Project Description

Proteomarkers Biotech [PMB] is an innovative biotechnology-oriented start-up company, specialized in the specialized in the development, design and production of new screening tests for the non-invasive prenatal detection of embryonic abnormalities and pregnancy complications. The company applies the state-of the-art technologies of proteomics and high-resolution mass spectrometry as the technology of choice for the development of its screening tests.

PMB introduces a family of innovative kits for the non-invasive prenatal test of embryonic abnormalities (Down syndrome, Turner syndrome etc) and pregnancy complications (pre-eclampsia, premature delivery, intra-uterine infections). Kits’ method is this of the identification of specific patented proteins (biomarkers) in the peripheral blood of pregnant women, by high resolution mass spectrometry